C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
about
Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticlesComplex of C60 Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy.Comparative Analysis of the Antineoplastic Activity of C60 Fullerene with 5-Fluorouracil and Pyrrole Derivative In Vivo.Cytotoxic Effects of Dimorfolido-N-Trichloroacetylphosphorylamide and Dimorfolido-N-Benzoylphosphorylamide in Combination with C60 Fullerene on Leukemic Cells and Docking Study of Their Interaction with DNA.Recent advances in carbon based nanosystems for cancer theranostics.A nanocomplex of C60 fullerene with cisplatin: design, characterization and toxicity.A nanocomplex of C60 fullerene with cisplatin: design, characterization and toxicity.Determination of the equilibrium constant of C60 fullerene binding with drug molecules.Fullerenes in Biology and Medicine.C60 Fullerene Effects on Diphenyl-N-(trichloroacetyl)-amidophosphate Interaction with DNA In Silico and Its Cytotoxic Activity Against Human Leukemic Cell Line In Vitro.C60 fullerene affects elastic properties and osmoregulation reactions of human lymphocytes.C60 Fullerenes Diminish Muscle Fatigue in Rats Comparable to N-acetylcysteine or β-Alanine.
P2860
Q28075551-15776461-93D2-45F6-8AC4-70CDD8E85AD7Q36415352-C04B7A14-1EF5-4F95-82D7-538EE3438109Q37562230-DFE728B0-4B26-4883-B3BA-192644F0099AQ37650538-C9C5224A-9364-4623-A282-7BAAE9DCF034Q39236622-F795729C-FB3A-4C54-8899-0AFA858DD84DQ47147900-DDCEB23C-7D1D-47EA-86D0-3F981C8C4534Q47682144-B38B0D8C-8E7F-4F39-9059-A894A0D05482Q47965910-7B243380-744D-4731-8F7F-3F24E34F9F3DQ49960476-42F49DE6-A6E3-4BA6-AE40-60EB76F6A2B3Q52360925-7BC5BD96-852C-4B00-A071-610F5C95BF5AQ53468716-B07C2218-3BE7-4E53-8FF2-B92859A7D0D5Q54963897-29C82282-51A7-467F-906B-475D2E83CF28
P2860
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
@ast
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
@en
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
@nl
type
label
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
@ast
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
@en
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
@nl
prefLabel
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
@ast
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
@en
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
@nl
P2093
P2860
P50
P1433
P1476
C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
@en
P2093
Maxim Evstigneev
Olga Matyshevska
Peter Scharff
Uwe Ritter
P2860
P304
P356
10.1007/S40268-014-0074-4
P577
2014-12-01T00:00:00Z